Microfluidic Mixer (LNP/Liposome Formation) – Validation Summary Report (VSR) Template

Validation Summary Report (VSR)

Equipment: Microfluidic Mixer (LNP/Liposome Formation)

Subcategory: NDDS – Liposomes & Lipid Nanoparticles (LNP)

Area: R&D/Production

DQ/IQ/OQ/PQ Flags

Design Qualification (DQ): Yes

Installation Qualification (IQ): Yes

Operational Qualification (OQ): Yes

Performance Qualification (PQ): Yes

Acceptance Criteria Reference

URS Annex 11 Annex 15

Key Critical Parameters

  • Flow Ratio
  • Total Flow Rate
  • Temperature
  • Mixing Time
  • Backpressure
  • Audit Trail

Requalification Frequency

12 Months

Summary

This Validation Summary Report documents the validation activities conducted for the Microfluidic Mixer used in the formation of Liposomes and Lipid Nanoparticles (LNP) within the R&D/Production area. The validation process included DQ, IQ, OQ, and PQ phases to ensure compliance with established acceptance criteria.

Scope/Boundaries

The scope of this validation encompasses the Microfluidic Mixer, its operational parameters, and its integration within the production workflow for LNPs and liposomes. The boundaries of this validation include all relevant equipment, processes, and personnel involved in the operation of the mixer.

Executed Protocol List

  • Protocol DQ-001: Design Qualification
  • Protocol IQ-001: Installation Qualification
  • Protocol OQ-001: Operational Qualification
  • Protocol PQ-001: Performance Qualification

Deviations Summary

No deviations were noted during the execution of the validation protocols. All critical parameters were met as per the acceptance criteria.

CPP Verification Summary

All Critical Process Parameters (CPPs) were verified during the OQ and PQ phases. The results confirmed that the Microfluidic Mixer operates within the specified limits for flow ratio, total flow rate, temperature, mixing time, backpressure, and audit trail.

Conclusion

The validation of the Microfluidic Mixer for LNP and liposome formation has been successfully completed. The equipment meets all specified acceptance criteria and is deemed suitable for use in the R&D/Production environment. Ongoing compliance will be maintained through regular requalification every 12 months.

See also  mAbs – PQ Protocol

Attachments Index

  • Attachment 1: DQ Protocol Report
  • Attachment 2: IQ Protocol Report
  • Attachment 3: OQ Protocol Report
  • Attachment 4: PQ Protocol Report

Approvals

Prepared by: [Name], [Title]

Reviewed by: [Name], [Title]

Approved by: [Name], [Title]